Share
Journal Information
Issue
Vol. 27. Issue 3.(May - June 2022)
Editorial
Is diabetes a risk factor for malignancy post-transplant in liver transplant recipients?
Stephen E. Congly
Ann Hepatol. 2022;27:100703
Open access
Opinions
The growing need to monitor the liver function after SARS-CoV-2 infection in the Mexican population with obesity
Juan José Rivera-Valdes, Erika Martínez-Lopez
Ann Hepatol. 2022;27:100698
Open access
Original articles
Identification of key genes associated with the progression of liver fibrosis to hepatocellular carcinoma based on iTRAQ proteomics and GEO database
Jiongyi Yan, Xuewan Fang, Yinyi Feng, Xiaojuan Cui, Fang Li, Weisheng Luo, Xiaocong Ma, Jianqin Liang, Jianfang Feng
Ann Hepatol. 2022;27:100681
Open access
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: A long-term follow-up study
Stefano Gitto, Paolo Magistri, Luca Marzi, Nicolò Mannelli, Nicola De Maria, Andrea Mega, Giovanni Vitale, Giovanna Valente, ... MEDITRA© group
Ann Hepatol. 2022;27:100683
Open access
Safety and efficacy of common endoscopic treatments in patients with decompensated liver cirrhosis
Hang Yang, Yi Mou, Bing Hu
Ann Hepatol. 2022;27:100689
Open access
Lysophosphatidylcholine acyltransferase 1 promotes epithelial-mesenchymal transition of hepatocellular carcinoma via the Wnt/β-catenin signaling pathway
Ling Shen, Peng Gu, Chen Qiu, Wen-tao Ding, Lei Zhang, Wan-yue Cao, Zu-yin Li, Bin Yan, Xing Sun
Ann Hepatol. 2022;27:100680
Open access
Spontaneous portosystemic shunt embolization in liver transplant recipients with recurrent hepatic encephalopathy
Patricia Álvarez-López, Isabel Campos-Varela, Sergi Quiroga, Iratxe Díez, Ramón Charco, Macarena Simón-Talero, Lluís Castells
Ann Hepatol. 2022;27:100687
Open access
An exploratory analysis of patient factors influencing acceptance of extended criteria liver grafts
William Shanahan, Benjamin Jacob, Colm McCarthy, Brian McDonnell, Ross MacNicholas
Ann Hepatol. 2022;27:100686
Open access
Seroprevalence of hepatitis B and C viruses in moderate and severe COVID-19 inpatients: A cross-sectional study at a referral center in Mexico
JC Jiménez-Mendoza, FE Rivera-López, MF González-Lara, RD Valdez-Echeverría, GE Castro-Narro, A Tore, LF Uscanga-Domínguez, C Moctezuma-Velázquez
Ann Hepatol. 2022;27:100684
Open access
Weekend catch-up sleep is associated with the alleviation of non-alcoholic fatty liver disease
Yongsang Seo, Gi-Ho Sung, Sangheun Lee, Ki Jun Han
Ann Hepatol. 2022;27:100690
Open access
HBX suppresses PTEN to promote the malignant progression of hepatocellular carcinoma through mi-R155 activation
Lian-Jie Niu, Tao Huang, Lianjiang Wang, Xian-Fu Sun, Ya-Min Zhang
Ann Hepatol. 2022;27:100688
Open access
The impact of COVID-19 on the cascade of care of HCV in the US and China
Yee Hui Yeo, Xu Gao, Jian Wang, Qingyu Li, Xingyang Su, Yu Geng, Rui Huang, Chao Wu, ... Walid S. Ayoub
Ann Hepatol. 2022;27:100685
Open access
Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy
Tianyi Liang, Yongfei He, Shutian Mo, Zijun Chen, Xiwen Liao, Xin Zhou, Chengkun Yang, Shuqi Zhao, ... Tao Peng
Ann Hepatol. 2022;27:100695
Open access
Liver cirrhosis is a risk factor for poor prognosis of acute cholangitis caused by choledocholithiasis
Miyuki Sensui, Shin Yasui, Sadahisa Ogasawara, Hidehiro Kamezaki, Motoyasu Kan, Shikiko Maruta, Toshihito Yamada, Yoshifumi Miura, ... Naoya Kato
Ann Hepatol. 2022;27:100696
Open access
Publish in
Annals of Hepatology
Affiliated societies
